A detailed history of Arden Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Arden Trust CO holds 1,781 shares of BIIB stock, worth $330,696. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,781
Previous 1,781 -0.0%
Holding current value
$330,696
Previous $384,000 7.29%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 03, 2024

SELL
$212.02 - $267.71 $32,863 - $41,495
-155 Reduced 8.01%
1,781 $384,000
Q4 2023

Jan 04, 2024

SELL
$222.59 - $267.94 $99,942 - $120,305
-449 Reduced 18.83%
1,936 $500,000
Q3 2023

Oct 10, 2023

BUY
$253.3 - $285.89 $1,519 - $1,715
6 Added 0.25%
2,385 $612,000
Q2 2023

Jul 14, 2023

SELL
$275.25 - $318.06 $290,388 - $335,553
-1,055 Reduced 30.72%
2,379 $678,000
Q1 2023

Apr 14, 2023

SELL
$256.56 - $292.34 $151,370 - $172,480
-590 Reduced 14.66%
3,434 $954,000
Q4 2022

Jan 20, 2023

SELL
$252.44 - $306.72 $100,723 - $122,381
-399 Reduced 9.02%
4,024 $0
Q3 2022

Oct 20, 2022

SELL
$194.69 - $268.46 $17,132 - $23,624
-88 Reduced 1.95%
4,423 $1.18 Million
Q2 2022

Jul 12, 2022

SELL
$187.54 - $223.02 $177,975 - $211,645
-949 Reduced 17.38%
4,511 $920,000
Q1 2022

Apr 11, 2022

SELL
$193.77 - $244.14 $66,850 - $84,228
-345 Reduced 5.94%
5,460 $1.15 Million
Q4 2021

Jan 24, 2022

SELL
$223.92 - $287.77 $643,546 - $827,050
-2,874 Reduced 33.11%
5,805 $1.39 Million
Q3 2021

Oct 12, 2021

SELL
$282.99 - $369.05 $43,297 - $56,464
-153 Reduced 1.73%
8,679 $2.46 Million
Q2 2021

Jul 19, 2021

BUY
$259.0 - $414.71 $93,758 - $150,125
362 Added 4.27%
8,832 $3.06 Million
Q1 2021

Apr 23, 2021

BUY
$242.95 - $284.63 $287,652 - $337,001
1,184 Added 16.25%
8,470 $2.37 Million
Q4 2020

Jan 15, 2021

SELL
$236.26 - $355.63 $264,847 - $398,661
-1,121 Reduced 13.33%
7,286 $1.78 Million
Q3 2020

Oct 15, 2020

SELL
$264.77 - $305.71 $349,761 - $403,842
-1,321 Reduced 13.58%
8,407 $2.39 Million
Q2 2020

Jul 09, 2020

BUY
$258.66 - $342.55 $335,999 - $444,972
1,299 Added 15.41%
9,728 $2.6 Million
Q1 2020

Apr 16, 2020

BUY
$268.85 - $341.04 $37,907 - $48,086
141 Added 1.7%
8,429 $2.67 Million
Q4 2019

Jan 17, 2020

SELL
$220.06 - $304.07 $99,027 - $136,831
-450 Reduced 5.15%
8,288 $2.46 Million
Q3 2019

Oct 09, 2019

BUY
$217.44 - $243.88 $217 - $243
1 Added 0.01%
8,738 $2.03 Million
Q2 2019

Jul 23, 2019

BUY
$219.29 - $241.72 $1.92 Million - $2.11 Million
8,737 New
8,737 $2.04 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Arden Trust CO Portfolio

Follow Arden Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.